Tutewohl Steve 4
4 · Evolent Health, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Tutewohl Steve
Chief Operating Officer
Transactions
- Tax Payment
Class A Common Stock
2023-03-01$35.26/sh−2,176$76,726→ 130,531 total - Tax Payment
Class A Common Stock
2023-03-02$35.15/sh−3,200$112,480→ 127,331 total - Award
Class A Common Stock
2023-03-01+17,011→ 132,707 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.